Data as of Dec 06
| +0.04 / +0.43%|
The 1 analysts offering 12-month price forecasts for Galectin Therapeutics Inc have a median target of 13.00, with a high estimate of 13.00 and a low estimate of 13.00. The median estimate represents a +40.09% increase from the last price of 9.28.
The current consensus among 1 polled investment analysts is to Buy stock in Galectin Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.